Drugs and Therapeutics (D & T) Committee
Meeting Results
June 25, 2008 |
| Drug Name |
Review Type |
Committee Recommendation |
Prior Approval Status – Final Determination |
| Duac CS |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
| Evoclin Foam |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
| Glumetza |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
| Cimzia |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
| Pristiq |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
| Treximet |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
| Bystolic |
New Drug Initial Review |
Removed from Agenda |
Prior Approval Required |
| Luvox CR |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
| Voltaren Gel |
New Drug Initial Review |
Require Prior Approval |
Prior Approval Required |
| Iquix |
New Drug Appeal |
Remove Prior Approval Requirement |
Prior Approval requirement removed |
| Sanctura XR |
New Drug Appeal |
Require Prior Approval |
Prior Approval Required |
| Vyvanse |
New Drug Appeal |
Require Prior Approval |
Prior Approval Required |
| Combigan |
New Drug Appeal |
Remove Prior Approval Requirement |
Prior Approval requirement removed |
| Vusion |
New Drug Appeal |
Removed from Agenda |
Prior Approval Required |
| Strattera |
PDL Appeal |
Remove Prior Approval Requirement |
Prior Approval Required |
| Lovaza |
PDL Appeal |
Require Prior Approval |
Prior Approval Required |
| Fazaclo |
PDL Appeal |
Remove Prior Approval Requirement |
Prior Approval requirement removed |